Molecular Cancer Research : Mcr

• 

  Publication Venue For

  • 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells..  18:671-684. 2020
  • SPHK1 Is a Novel Target of Metformin in Ovarian Cancer..  17:870-881. 2019
  • Targeting CREB Pathway Suppresses Small Cell Lung Cancer..  16:825-832. 2018
  • Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition..  16:599-609. 2018
  • Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis..  16:554-563. 2018
  • The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma..  14:344-353. 2016
  • Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma..  14:287-295. 2016
  • p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.  13:584-591. 2015
  • S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer.  11:1542-1553. 2013
  • A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent.  11:219-229. 2013
  • Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells..  9:1718-1731. 2011
  • RGS-GAIP-interacting protein controls breast cancer progression..  8:1591-1600. 2010
  • Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism..  7:745-754. 2009
  • Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy..  7:199-209. 2009
  • KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin..  7:230-236. 2009
  • Yin yang 1 modulates taxane response in epithelial ovarian cancer..  7:210-220. 2009
  • Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene..  6:843-850. 2008
  • DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture..  6:517-524. 2008
  • A message from the editor.  5. 2007
  • Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis..  5:705-711. 2007
  • Editor's note.  5. 2007
  • Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer..  4:283-292. 2006
  • A mechanism of COOH-terminal binding protein-mediated repression..  3:575-583. 2005
  • TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein..  2:442-452. 2004
  • Chromatin association of rad17 is required for an ataxia telangiectasia and rad-related kinase-mediated S-phase checkpoint in response to low-dose ultraviolet radiation..  2:362-369. 2004
  • Molecular Cancer Research: A Note from the Editor.  1. 2003
  • Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival..  1:1036-1047. 2003
  • Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage..  1:674-681. 2003
  • Molecular markers in ductal carcinoma in situ of the breast..  1:362-375. 2003
  • Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx..  1:280-289. 2003
  • Welcome to molecular cancer research.  1:1. 2002
  • Dysregulated Hippo signaling in childhood rhabdomyosarcoma. 2020
  • Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth. 2020
  • Loss of noncanonical Hippo signaling in fusion-positive alveolar rhabdomyosarcoma increases invasiveness and a dedifferentiated phenotype associated with metastasis. 2020
  • NUAK2 inhibition for prostate cancer. 2020